SCHEMBL13305591

SCHEMBL13305591

Cc1cnn2c(NCc3ccc(=O)[nH]c3)cc(C3CCCCC3)nc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 4/20 0.52
▸ CHEK1 O14757 6/20 0.44
▸ CDK2 P24941 5/20 0.44
▸ CCNA2 P20248 1/20 0.44
▸ CCNA1 P78396 1/20 0.44
▸ CDK1 P06493 3/20 0.41
▸ CDK9 P50750 2/20 0.41
▸ CDK5 Q00535 2/20 0.41
▸ PDE10A Q9Y233 1/20 0.38
▸ PDE9A O76083 2/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ CCNE1 P24864 2/20 0.35
▸ CDK7 P50613 2/20 0.35
▸ CCNH P51946 2/20 0.35
▸ MNAT1 P51948 2/20 0.35
▸ PSD A5PKW4 1/20 0.34
▸ GPR39 O43194 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13146493 0.89 GSK3B (0.52) GSK3BCHEK1CDK2CCNA2CCNA1
SCHEMBL12953224 0.89 GSK3B (0.66) GSK3BCHEK1CDK2CCNA2CCNA1
SCHEMBL13305605 0.81 GSK3B (0.55) GSK3BCHEK1CDK2CCNA2CCNA1
SCHEMBL13305023 0.79 GSK3B (0.49) GSK3BCHEK1CDK2CCNA2CCNA1
SCHEMBL13304928 0.73 GSK3B (0.51) GSK3BCHEK1CDK2CCNA2CCNA1
SCHEMBL13304607 0.72 GSK3B (0.79) GSK3BCHEK1CDK2CCNA2CCNA1
SCHEMBL27370870 0.72 CDK2 (0.47) GSK3BCDK2CCNA2CCNA1CDK1
SCHEMBL14050830 0.72 GSK3B (0.68) GSK3BCHEK1CDK2CCNE1
SCHEMBL13305295 0.72 GSK3B (0.81) GSK3BCHEK1CDK2CCNA2CCNA1
SCHEMBL13305375 0.71 GSK3B (0.57) GSK3BCHEK1CDK2CCNA2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537116-B1 PYRAZOLOPYRIMIDINES SUITABLE FOR THE TREATMENT OF CANCER DISEASES SCHERING CORP (US) 2010-06-02 — — EP disclosed
Send feedback